CorMedix (CRMD) Earnings Date & Reports

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

CRMD is expected to report earnings to fall 135.17% to -10 cents per share on November 11

Q3'26

Est.

$-0.10

Q2'26

Beat

by $0.06

Q1'26

Missed

by $0.02

Q4'25

Missed

by $0.69

Q3'25

Beat

by $0.83

The last earnings report on August 13 showed earnings per share of 28 cents, beating the estimate of 23 cents. With 498.81K shares outstanding, the current market capitalization sits at 614.98M.

View a ticker or compare two or three

CRMD

Daily Signal:

Gain/Loss:

Trend Trader for RUSSELL 2000: Magic Formula & Optimal Structure, 60min, (FA)Trend Trader for RUSSELL 2000: Magic Formula & Optimal Structure, 60min, (FA)

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement